Citations 44
Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (P6.098)
Halker, Rashmi, Tepper, Stewart J. , Shulman, Kenneth, Wallick, Christopher J.
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (I3.009)
Halker, Rashmi, Tepper, Stewart J. , Shulman, Kenneth, Wallick, Christopher J.
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)
Starling, Amaal J. , Tepper, Stewart J. , Shamim, Ejaz A. , Hindiyeh, Nada , Silberstein, Stephen D., Marmura, Michael J. , Robbins, Matthew S. , Charles, Andrew , Goadsby, Peter J. , Lipton, Richard B. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
Risk of Hypertension in Erenumab-treated Patients With Migraine in Clinical Trials and in the Postmarketing Setting (2168)
Tepper, Stewart J. , Pannacciulli, Nico, Navetta, Marco S., Zhang, Feng, Choudhry, Jessica, Dodick, David W. , Ailani, Jessica , Xue, Fei , Zhang, Feng
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870)
Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Eptinezumab Demonstrated Migraine Preventive Efficacy on Day 1 After Dosing: Closed Testing Analysis from PROMISE-1 and PROMISE-2 (617)
Gottschalk, Christopher , Tepper, Stewart J. , Cady, Roger , Smith, Jeff , Hirman, Joe, Snapinn, Steve, Dodick, David W. , Friedman, Deborah I.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlović, Jelena , Tepper, Stewart J. , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Friedman, Deborah I. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Benefit of Migraine Prevention with Erenumab in Patients Receiving Background Standard-of-care Acute Treatment (1381)
Starling, Amaal J. , Tepper, Stewart J. , Bernstein, Carolyn , Chou, Denise E. , Ailani, Jessica , Zhang, Feng , Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Cardiovascular Safety of Erenumab in Patients with Migraine and Aura (1209)
Tepper, Stewart J. , Xue, Fei , Olearczyk, J, Ashina, Messoud , Goadsby, Peter J. , Dodick, David W. , Zhang, Feng , Olearczyk, Jeffrey, Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Real-World Healthcare Costs and Resource Utilization Among Patients Treated With Erenumab in the United States: A Retrospective Claims Database Study (P16-7.003)
Tepper, Stewart J. , Vo, Pamela, Joshi, Parth, Abdrabboh, Ahmad, Ferraris, Matias, Tiwari, Santosh , Schwedt, Todd J. , Glassberg, Mrudula B. , Tiwari, Santosh, Thompson, Jeffrey A.
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available